1. Home
  2. TARS vs UE Comparison

TARS vs UE Comparison

Compare TARS & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$81.11

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Urban Edge Properties of Beneficial Interest

UE

Urban Edge Properties of Beneficial Interest

HOLD

Current Price

$19.22

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
UE
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TARS
UE
Price
$81.11
$19.22
Analyst Decision
Strong Buy
Hold
Analyst Count
9
5
Target Price
$76.56
$22.00
AVG Volume (30 Days)
404.5K
661.6K
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
3.98%
EPS Growth
N/A
N/A
EPS
N/A
0.89
Revenue
$366,100,000.00
$468,742,000.00
Revenue This Year
$147.24
$6.50
Revenue Next Year
$53.11
N/A
P/E Ratio
N/A
$21.58
Revenue Growth
182.44
7.71
52 Week Low
$38.51
$15.66
52 Week High
$85.25
$22.84

Technical Indicators

Market Signals
Indicator
TARS
UE
Relative Strength Index (RSI) 59.46 50.54
Support Level $77.44 $18.79
Resistance Level $85.25 $19.44
Average True Range (ATR) 3.56 0.38
MACD -0.32 0.04
Stochastic Oscillator 55.84 69.84

Price Performance

Historical Comparison
TARS
UE

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: